Andreas Hallqvist

SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC

Jan Nyman, Andreas Hallqvist, Jo-Åsmund Lund et al. · Radiotherapy and Oncology · 2016 · 339 citations · Full text

Inoperable Stage, Radiation Medicine, Radiation Therapy +8

Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients

Anna Sundlöv, Katarina Sjögreen Gleisner, Jan Tennvall et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 71 citations · Full text

Intraperitoneal α-Emitting Radioimmunotherapy with²¹¹At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose Estimations

Andreas Hallqvist, Karin Bergmark, Tom Bäck et al. · Journal of Nuclear Medicine · 2019 · 70 citations · Full text

Concurrent cetuximab and radiotherapy after docetaxel–cisplatin induction chemotherapy in stage III NSCLC: Satellite—A phase II study from the Swedish Lung Cancer Study Group

Andreas Hallqvist, Gunnar Wagenius, H. Rylander et al. · Lung Cancer · 2010 · 53 citations

Radiation Medicine, Radiation Therapy, Medicine +10

Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab – Pooled results from two prospective clinical trials

Andreas Hallqvist, Bengt Bergman, Jan Nyman · Radiotherapy and Oncology · 2012 · 29 citations

Health Related Quality, Quality Of Life, Advanced Nsclc +9